Union health ministry officials on Thursday clarified that the intent of the Indian Council of Medical Research director general's letter envisaging the launch of COVID-19 vaccine by August 15 was......
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on' ......
An estimated one crore frontline health workers will received the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of......
India's apex medical body Indian Council of Medical Research said on Friday that it aims to launch the world's first COVID-19 vaccine, the indigenously developed Covaxin, by August 15, and has......
Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India an emergency use authorisation for its COVID-19 vaccine in the country, after its parent......
Cadila Healthcare Ltd has announced that Zydus Cadila has received its very first approval from USFDA to market Atenolol, an anti-hypertensive drug, in the US market. Following this, the group......
Zydus Cadila Healthcare Ltd on Tuesday said it has received approval from the French regulatory agency, AFSSAPS, to market Sertraline capsules 25 mg and 50 mg, in the French market.Sertraline is an......
Cadila Healthcare Ltd board approved amalgamation of German Remedies Ltd, Recon Healthcare Ltd, Zydus Pathline Ltd & Zoom Properties Ltd with the company.The boards of Cadila Health Care and German......
Cadila Healthcare Ltd has informed BSE that pursuant to Order dated January 31, 2003 passed by Hon'ble High Court of Gujarat in the matter of approval of Scheme of Amalgamation of German Remedies......
Ahmedabad-based pharmaceutical major Zydus Cadila Healthcare Ltd has made a foray into the lucrative French generics market with the launch of 43 generics there.Being launched through Zydus France......